Literature DB >> 21951287

Cholesterol synthesis-related enzyme oxidosqualene cyclase is required to maintain self-renewal in primary erythroid progenitors.

C Mejia-Pous1, F Damiola, O Gandrillon.   

Abstract

OBJECTIVES: Molecular mechanisms controlling cell fate decision making in self-renewing cells are poorly understood. A previous transcriptomic study, carried out in primary avian erythroid progenitor cells (T2ECs), revealed that the gene encoding oxidosqualene cyclase (OSC/LSS), an enzyme involved in cholesterol biosynthesis, is significantly up-regulated in self-renewing cells. The aim of the present work is to understand whether this up-regulation is required for self-renewal maintenance and what are the mechanisms involved.
MATERIALS AND METHODS: To investigate OSC function, we studied effects of its enzymatic activity inhibition using Ro48-8071, a specific OSC inhibitor. In addition, we completed this pharmacological approach by RNAi-mediated OSC/LSS knockdown. The study of OSC inhibition was carried out on both self-renewing and differentiating cells to observe any state-dependent effect.
RESULTS: Our data show that OSC acts both by protecting self-renewing T2EC cells from apoptosis and by blocking their differentiation program, as OSC inhibition is sufficient to trigger spontaneous commitment of self-renewing cells towards an early differentiation state. This is self-renewal specific, as OSC inhibition has no effect on erythroid progenitors that have already differentiated.
CONCLUSIONS: Taken together, our results suggest that OSC/LSS expression and activity are required to maintain cell self-renewal and may be involved in the self-renewal versus differentiation/apoptosis decision making, by keeping cells in a self-renewal state.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951287      PMCID: PMC6495882          DOI: 10.1111/j.1365-2184.2011.00771.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  55 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains.

Authors:  S Roy; R Luetterforst; A Harding; A Apolloni; M Etheridge; E Stang; B Rolls; J F Hancock; R G Parton
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

3.  Role of the different RAR isoforms in controlling the erythrocytic differentiation sequence. Interference with the v-erbA and p135gag-myb-ets nuclear oncogenes.

Authors:  O Gandrillon; J Samarut
Journal:  Oncogene       Date:  1998-02-05       Impact factor: 9.867

4.  Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened.

Authors:  James K Chen; Jussi Taipale; Michael K Cooper; Philip A Beachy
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

5.  Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis.

Authors:  Jenny Wong; Carmel M Quinn; Ingrid C Gelissen; Andrew J Brown
Journal:  J Biol Chem       Date:  2007-11-02       Impact factor: 5.157

6.  Stem cell antigen 2: a new gene involved in the self-renewal of erythroid progenitors.

Authors:  C Bresson-Mazet; O Gandrillon; S Gonin-Giraud
Journal:  Cell Prolif       Date:  2008-10       Impact factor: 6.831

7.  Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice.

Authors:  Xinghua Zhou; Thomas P Johnston; Daniel Johansson; Paolo Parini; Keiko Funa; Jan Svensson; Göran K Hansson
Journal:  Atherosclerosis       Date:  2008-10-25       Impact factor: 5.162

Review 8.  Balancing acts: molecular control of mammalian iron metabolism.

Authors:  Matthias W Hentze; Martina U Muckenthaler; Nancy C Andrews
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

Review 9.  Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?

Authors:  Daniel S Ory
Journal:  Circ Res       Date:  2004-10-01       Impact factor: 17.367

10.  c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.

Authors:  O Gandrillon; N Ferrand; J J Michaille; L Roze; M H Zile; J Samarut
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

View more
  10 in total

1.  Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development.

Authors:  Jose A Hernandez; Victoria L Castro; Nayeli Reyes-Nava; Laura P Montes; Anita M Quintana
Journal:  Blood Adv       Date:  2019-04-23

2.  Single-Cell-Based Analysis Highlights a Surge in Cell-to-Cell Molecular Variability Preceding Irreversible Commitment in a Differentiation Process.

Authors:  Angélique Richard; Loïs Boullu; Ulysse Herbach; Arnaud Bonnafoux; Valérie Morin; Elodie Vallin; Anissa Guillemin; Nan Papili Gao; Rudiyanto Gunawan; Jérémie Cosette; Ophélie Arnaud; Jean-Jacques Kupiec; Thibault Espinasse; Sandrine Gonin-Giraud; Olivier Gandrillon
Journal:  PLoS Biol       Date:  2016-12-27       Impact factor: 8.029

Review 3.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

4.  The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.

Authors:  Florian H Heidel; Lars Bullinger; Patricia Arreba-Tutusaus; Zhu Wang; Julia Gaebel; Carsten Hirt; Dietger Niederwieser; Steven W Lane; Konstanze Döhner; Valera Vasioukhin; Thomas Fischer; Scott A Armstrong
Journal:  J Exp Med       Date:  2012-12-31       Impact factor: 14.307

5.  2,3-Oxidosqualene cyclase protects liver cells from the injury of intermittent hypoxia by regulating lipid metabolism.

Authors:  Yue-Qiao Zhen; Yu-Min Wu; Yan-Hong Sang; Yan Wang; Qiu-Yan Song; Ling Yu; Xiao-Juan Rao; Rui-Hong Dong
Journal:  Sleep Breath       Date:  2015-04-09       Impact factor: 2.816

6.  Zebrafish ETV7 regulates red blood cell development through the cholesterol synthesis pathway.

Authors:  Anita M Quintana; Fabrizio Picchione; Ramon I Klein Geltink; Michael R Taylor; Gerard C Grosveld
Journal:  Dis Model Mech       Date:  2013-12-19       Impact factor: 5.758

7.  Functional analysis of the zebrafish ortholog of HMGCS1 reveals independent functions for cholesterol and isoprenoids in craniofacial development.

Authors:  Anita M Quintana; Jose A Hernandez; Cesar G Gonzalez
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

8.  Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells.

Authors:  Yayun Liang; Sandy Goyette; Salman M Hyder
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-07

9.  Erythroid differentiation displays a peak of energy consumption concomitant with glycolytic metabolism rearrangements.

Authors:  Angélique Richard; Elodie Vallin; Caroline Romestaing; Damien Roussel; Olivier Gandrillon; Sandrine Gonin-Giraud
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

10.  The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.

Authors:  Federica Maione; Simonetta Oliaro-Bosso; Claudia Meda; Federica Di Nicolantonio; Federico Bussolino; Gianni Balliano; Franca Viola; Enrico Giraudo
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.